Biotechnology Archives - Page 4 of 6

Big news in the great “AI Boom or AI Bust” debate

Big news in the great “AI Boom or AI Bust” debate as semiconductor stocks hit new highs, reinforcing the strength of the AI bull case while weighing both sides of this critical market trend.

By Brian Hunt | January 28, 2026

Read this issue

Intuitive Surgical Beats Q4 Earnings: Why This Rival is a Smarter Buy

Intuitive Surgical crushed Q4 earnings, but its stock looks pricey. See why a key competitor could be a smarter way to play the booming robotic-surgery market.

By Jeff Havenstein | January 23, 2026

Read this issue

This AI power trade is taking off. Are you on board?

Get ready for higher prices. The bull market in solar energy is back on. Over the past four months, I’ve repeatedly made the case for owning solar energy stocks.

By Brian Hunt | January 22, 2026

Read this issue

Why Alzheimer’s Drug Sales Are Set to Surge: Three Key Insights for Biotech Investors

Alzheimer's drug sales are gaining momentum as Leqembi and Kisunla expand globally and new P-Tau blood tests transform diagnosis. Here's what biotech investors need to know.

By Dave Lashmet | December 9, 2025

Read this issue

Stock Market Investors: This Is No Time to Panic

The S&P pullback isn’t breaking the bull trend. Inside: why this isn’t a time to panic, homebuilder rebound potential, biotech strength, and an AMZN trade setup.

By Brian Hunt | November 21, 2025

Read this issue

A Boomer Health Care Play Soars to New All-Time Highs: Are You Benefiting From This Megatrend?

Boomer health care stocks, biotech winners, and top oil names are hitting new highs. Here’s what’s driving these megatrends in today’s Money & Megatrends.

By Brian Hunt | November 18, 2025

Read this issue

Biotechnology

Article Date Range

Author

Categories

Big news in the great “AI Boom or AI Bust” debate

Intuitive Surgical Beats Q4 Earnings: Why This Rival is a Smarter Buy

This AI power trade is taking off. Are you on board?

Why Alzheimer’s Drug Sales Are Set to Surge: Three Key Insights for Biotech Investors

Stock Market Investors: This Is No Time to Panic

A Boomer Health Care Play Soars to New All-Time Highs: Are You Benefiting From This Megatrend?